Skip to main content

Advertisement

SpringerLink
Log in

Challenges in Developing Robust Genetic Markers and Targets to Predict and Prevent Distant and Peritoneal Recurrence in Gastric Cancer

  • Gastrointestinal Oncology
  • Published:
Annals of Surgical Oncology Aims and scope Submit manuscript

This is a preview of subscription content, log in via an institution to check access.

Access this article

Log in via an institution

Price excludes VAT (USA)
Tax calculation will be finalised during checkout.

Instant access to the full article PDF.

Institutional subscriptions

References

  1. Mimori K, Fukagawa T, Kosaka Y, Ishikawa K, Etoh T, Sasako M, et al. A large-scale study of MT1-MMP as a marker for isolated tumor cells in peripheral blood and bone marrow in gastric cancer cases. Ann Surg Oncol. 2008;15(10):2934–2942.

    Article  PubMed  Google Scholar 

  2. Roukos DH. Innovative genomic-based model for personalized treatment of gastric cancer: integrating current standards and new technologies. Expert Rev Mol Diagn. 2008;8(1):29–39.

    Article  PubMed  CAS  Google Scholar 

  3. Liakakos T, Roukos DH. More controversy than ever—challenges and promises towards personalized treatment of gastric cancer. Ann Surg Oncol. 2008;15(4):956–60.

    Article  PubMed  Google Scholar 

  4. Roukos DH. Genetics and genome-wide association studies: surgery-guided algorithm and promise for future breast cancer personalized surgery. Expert Rev Mol Diagn. 2008;8(5):587–97.

    Article  PubMed  Google Scholar 

  5. Roukos DH. Assessing both genetic variation (SNPs/CNVs) and gene-environment interactions may lead to personalized gastric cancer prevention. Expert Rev Mol Diagn. 2009; 9(1):1–6.

    Article  PubMed  CAS  Google Scholar 

  6. Gupta GP, Nguyen DX, Chiang AC, Bos PD, Kim JY, Nadal C, et al. Mediators of vascular remodeling co-opted for sequential steps in lung metastasis. Nature. 2007 Apr 12;446(7137):765–70.

    Article  PubMed  CAS  Google Scholar 

  7. Sasako M, Sano T, Yamamoto S, Kurokawa Y, Nashimoto A, Kurita A, et al. for Japan Clinical Oncology Group. D2 lymphadenectomy alone or with para-aortic nodal dissection for gastric cancer. N Engl J Med. 2008;359(5):453–62.

    Article  PubMed  CAS  Google Scholar 

  8. Sakuramoto S, Sasako M, Yamaguchi T, Kinoshita T, Fujii M, Nashimoto A, et al. Adjuvant chemotherapy for gastric cancer with S-1, an oral fluoropyrimidine. N Engl J Med. 2007;357:1810–20.

    Article  PubMed  CAS  Google Scholar 

  9. Roukos DH, Kappas AM. Perspectives in the treatment of gastric cancer. Nat Clin Pract Oncol. 2005;2:98–107.

    Article  PubMed  Google Scholar 

  10. Kappas AM, Roukos DH. Quality of surgery determinant for the outcome of patient with gastric cancer. Ann Surg Oncol. 2002;9(9):828–30.

    Article  PubMed  Google Scholar 

  11. Roukos DH. Breast-cancer stromal cells with TP53 mutations. N Engl J Med. 2008;358(15):1636; author reply 1636.

    PubMed  CAS  Google Scholar 

  12. Vineis P, Brennan P, Canzian F, Ioannidis JPA, Matullo G, Ritchie M, et al. Expectations and challenges stemming from genome-wide association studies. Mutagenesis. 2008;23:439–44.

    Article  PubMed  CAS  Google Scholar 

  13. Ziogas D, Baltogiannis G, Fatouros M, Roukos DH. Identifying and preventing high-risk gastric cancer individuals with CDH1 mutations. Ann Surg. 2008;247(4):714–5.

    Article  PubMed  Google Scholar 

  14. Roukos DH. Linking contralateral breast cancer with genetics. Radiother Oncol. 2008;86:139–41.

    Article  PubMed  Google Scholar 

  15. Fatouros M, Baltoyiannis G, Roukos DH. The predominant role of surgery in the prevention and new trends in the surgical treatment of women with BRCA1/2 mutations. Ann Surg Oncol. 2008;15(1):21–33.

    Article  PubMed  Google Scholar 

  16. Roukos DH. HER2 and response to paclitaxel in node-positive breast cancer. N Engl J Med. 2008;358:197, author reply 198.

    Article  PubMed  CAS  Google Scholar 

  17. Manolio TA, Brooks LD, Collins FS. A HapMap harvest of insights into the genetics of common disease. J Clin Invest. 2008;118:1590–605.

    Article  PubMed  CAS  Google Scholar 

  18. Roukos DH, Lykoudis E, Liakakos T. Genomics and challenges toward personalized breast cancer local control. J Clin Oncol. 2008;26(26):4360–1.

    Article  PubMed  Google Scholar 

  19. Roukos DH. Personal genomics and genome-wide association studies: novel discoveries but limitations for practical personalized medicine. Ann Surg Oncol. 2008 Aug 23. [Epub ahead of print] DOI: 10.1245/s10434-008-0109-6.

Download references

Author information

Authors and Affiliations

  1. Biobank Personalized Cancer Biomedicine, Department of Surgery, School of Medicine, University of Ioannina, Ioannina, Greece

    D. Ziogas MD & D. H. Roukos MD

Authors
  1. D. Ziogas MD
    View author publications

    You can also search for this author in PubMed Google Scholar

  2. D. H. Roukos MD
    View author publications

    You can also search for this author in PubMed Google Scholar

Corresponding author

Correspondence to D. H. Roukos MD.

Rights and permissions

Reprints and permissions

About this article

Cite this article

Ziogas, D., Roukos, D.H. Challenges in Developing Robust Genetic Markers and Targets to Predict and Prevent Distant and Peritoneal Recurrence in Gastric Cancer. Ann Surg Oncol 16, 1068–1069 (2009). https://doi.org/10.1245/s10434-008-0300-9

Download citation

  • Received:

  • Accepted:

  • Published:

  • Issue Date:

  • DOI: https://doi.org/10.1245/s10434-008-0300-9

Keywords

Search

Navigation